Addressing the root cause of rare neurological diseases through next-generation gene editing
Evox Therapeutics is redefining the treatment of rare neurological and neurodegenerative diseases by harnessing the power of next-generation genome editing technologies.
Backed by leading investors and partners, Evox is advancing an innovative, proprietary pipeline targeting severe neurodegenerative conditions such as ALS and SCA2, while also unlocking broader opportunities across genetic and non-genetic central nervous system diseases. We are dedicated to transforming patient outcomes through cutting-edge science and unparalleled therapeutic innovation.
ExoEdit™
Evox has developed ExoEdit™, a proprietary genome-editing technology that harnesses the natural delivery power of exosomes, tiny vesicles naturally produced by cells, to precisely transport CRISPR-based editing tools into specific organs and cells. This approach is particularly effective for reaching tissues traditionally difficult to treat, such as those within the central nervous system. By safely encapsulating genome-editing ribonucleoproteins within exosomes, ExoEdit™ achieves highly targeted, efficient gene editing. The exosome’s natural origin ensures excellent safety, tolerability, and broad cell accessibility, allowing transient exposure to the editing machinery, which naturally degrades after its therapeutic effect, reducing long-term risks. Furthermore, Evox’s flexible platform enables adaptation to multiple genome-editing modalities and therapeutic areas, offering the potential for repeated dosing to achieve optimal therapeutic outcomes. ExoEdit™ has transformative potential to tackle severe diseases that have remained beyond the reach of existing treatments.
At Evox, values are at the heart of how we operate, how we behave, and how we will drive the growth of our exciting company.
We developed the values internally with all our employees, ones which we could all identify and work with. The personal and professional development of our employees is important to us, and we strive to provide formal and informal feedback throughout the year.
This is the way we work at Evox.
Our Values
Teamwork
Respect
Accountability
We
strive for excellence
